Baylor St. Luke's Medical Center is the private adult teaching hospital of Baylor College of Medicine jointly owned with CHI St. Luke's Health. The medical staff at the hospital includes full-time Baylor faculty, as well as community physicians.

During the past decade, Baylor St. Luke's Medical Center conducted 81 clinical trials. In the 10-year time frame, 81 clinical trials started and 45 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 25 clinical trials were completed. i.e. 75.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baylor St. Luke's Medical Center" #1 sponsor was "Baylor College of Medicine" with 12 trials, followed by "National Cancer Institute (NCI)" with 10 trials sponsored, "Bristol-Myers Squibb" with 8 trials sponsored, "Abbott Medical Devices" with 7 trials sponsored and "Ancora Heart, Inc." with 7 trials sponsored. Other sponsors include 69 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor St. Luke's Medical Center" #1 collaborator was "Baylor College of Medicine" with 3 trials as a collaborator, "Cedars-Sinai Medical Center" with 2 trials as a collaborator, "Columbia University" with 2 trials as a collaborator, "Harvard University" with 2 trials as a collaborator and "Medical University of South Carolina" with 2 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "Baylor St. Luke's Medical Center" are "Heart Failure" (6 trials), "Atrial Fibrillation" (4 trials), "Hepatitis C" (4 trials), "Coronary Artery Disease" (3 trials) and "Heart Diseases" (3 trials). Many other conditions were trialed in "Baylor St. Luke's Medical Center" in a lesser frequency.

Most popular intervention types in "Baylor St. Luke's Medical Center" are "Drug" (54 trials), "Device" (40 trials), "Biological" (17 trials), "Other" (16 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Laboratory Biomarker Analysis" (8 trials), "Bevacizumab" (4 trials), "Cisplatin" (3 trials) and "Daclatasvir" (3 trials). Other intervention names were less common.

The vast majority of trials in "Baylor St. Luke's Medical Center" are 113 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 51 active trials in "Baylor St. Luke's Medical Center". 1 are not yet recruiting, 27 are recruiting, 22 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 53 completed trials in Baylor St. Luke's Medical Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Baylor St. Luke's Medical Center, 11 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 37 trials that are defined as “Not Applicable".

Baylor St. Luke's Medical Center has several departments that took part in Clinical trials: "Texas Heart Institute at St. Luke's Episcopal Hospital" - 23 trials